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AIMS = Abnormal Involuntary Movement Scale
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DSM-IV = Diagnostic and Statistical Manual IV
GAF = Global Assessment of Functioning
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ABSTRACT
•

•

•

•

Background: Early intervention in psychosis is an opportunity. Research ahs shown that if any thing
community members can do to prevent psychosis is to report early. This has opened newer vistas for
understanding the complexity of brain and behaviour in schizophrenia. At the same time it has raised the
bar of expectations regarding its correlation to outcome. It finally narrows down to meaningful public
campaign for awareness, which will decide success of research to clinics in schizophrenia management.
Duration of untreated psychosis (DUP) has emerged as a reliable predictor of outcome and provides
credence to development of early intervention services. It is not quite clear if DUP works in isolation and
what other factors along with DUP would determine outcome long-term outcome of schizophrenia is
multifactorial in nature. The present study examines effect of DUP on outcome of schizophrenia
Method: we conducted a ten years follow up study of first episode hospitalized DSM III-R schizophrenia
and correlated multiple outcome criteria with DUP at Mumbai. We carefully determined onset of
psychosis using criteria for appearance of positive symptoms, negative symptoms or significant social
decline. Data was analyzed using SAS.
Results: we analyzed 101 patients available at ten years. We found that mean DUP was higher for group,
which showed Clinical recovery on GCIS [14.0(SD=8.0) months for recovered & 10.8 (SD=5.7) months in
nonrecovered group p=0.091]. There is a significant difference in favour of DUP≤6 months in terms of
subscales of PANSS; However DUP was not found to be significantly associated with the end point
parameters of good clinical or social outcome.
Conclusion: We find that DUP is just one factor in determinants of outcome. Several other
psychopathological & phenomenological factors collectively play a role in determining outcome. Future
research needs to be directed towards combination of determinants of outcome in early intervention of
psychosis

Introduction
•
•

There has been intense interest in DUP because of the proposal that psychosis is some
how neurologically toxic 1. If this is true then delay in treating people with psychosis could
impair prognosis, while reducing delay could improve it 7. However despite the blossoming
of early intervention services, there is continuing disagreement over whether there is a real
association between DUP and outcome. Several conflicting evidence have been reported
2,3,4 .
• Though DUP has been reported as an independent marker of outcome, measurement
errors and variability in DUP in terms of heterogeneity have also been reported and caution
advised 5,6,. The strength of association between DUP and outcome has been found to be
only ‘moderately strong’ based upon the available data, accounting for approximately 13%
of variance or 1 in 3 to 1 in 4 of those who did not achieve remission 7. Until now, very few
long-term studies have examined this association. Long-term outcome of schizophrenia is
multifactorial in nature. It not clearly known if short DUP is a strong determinant of longterm outcome. 8. The present study examines effects of DUP on clinical and social
outcome in ten year’s long-term follow up in a cohort of first episode psychosis.

Methods
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Design
This study is a naturalistic, prospective, longitudinal follow-up study conducted at Mumbai, India.
Assessments were conducted at the baseline and at the end of ten years follow up by trained and
experienced clinical research staff. Inter-rater reliability was established for quantification of outcome.
Sample and settings
Two hundred patients admitted with first episode psychosis were recruited as per inclusion criteria, and
101 were available at the end point. Wherever necessary patients were traced, contacted and assessed.
Inclusion criteria:
At base
Hospitalized
Availability of key relatives;
Confirmed diagnosis of psychotic disorder- non-affective as per DSM-III-R;
Age range of 18-45 years
Informed consent for participation in the study.
At end point
Reconfirmed diagnosis of schizophrenia as per DSM IV –TR 9 at the follow up of ten tears;
Informed consent
Available objective data from key relative

Criteria
• Exclusion criteria: we excluded cases of primary organic
psychotic disorder intellectual disability, drug and substance
induced psychosis, any change in diagnosis from baseline to
endpoint and epilepsy. comorbid alcoholism and substance
abuse.
• The study was carried out in a non-governmental, psychiatric
hospital certified as a psychiatric facility by the State
Government as per Indian Mental Health Act 1983 from a
period of 1993 to 2007. Independent Ethics Commission,
Mumbai, approved the study.
• Informed consent: All patients and their relatives were
explained the nature and purpose of study and an informed
consent was obtained at the beginning of the study as well as
at the end of the follow up for repeat assessment.
•

Assessment of DUP
• The assessment of duration of untreated psychosis was done
clinically by a detailed interview with the patient and the key
relatives. . We carefully assessed known prodromal signs and
tried to elicit the time of first-distressing symptoms either
positive or negative symptom to decode the onset of illness
• Positive symptoms (hallucinations, delusions, and odd beliefs
thought disorder)
• Negative symptoms (depression, dysphoria, apathy, anergia,
apathy, and amotivation)
• Social decline (withdrawn behavior, poor interpersonal
relationship, social avoidance, and lack of interest in
education or work)
• Assessment tools

• We used Clinical and social outcome criteria based upon Meltzer’s
outcome 10 criteria recommendations. We operational zed the
definition on a scale of 1-to-5 where one represented poorest and 5
the best outcome for some of the parameters. This scale was
developed for the local conditions and used in other studies 11
Clinical Outcome was measured by 1] Clinical Global impression
scale (CGIS) 12 2] Psychopathology (positive symptoms, negative
symptoms and disorganization) using Positive and Negative
syndrome scale [PANSS]) 13 l., 1987), 3] Depressive symptoms
using Hamilton Depression Rating Scale (HDRS) 14, 4] Factors of
Compliance, 5] EPS, using Abnormal Involuntary Movement
Scale(AIMS) 15 6] Aggression, 7] Hospitalization, and 8] Suicidality.
Social outcome was measured using 1] Quality of life 16, 2] Global
Functioning using GAF, 17. 18 3] Independent living, 4] Family
burden, and 5] Social burden measured operationalized criteria.
Raters in this study were not blinded.

Outcome criteria
• We used GCIS for measuring severity as well as improvement
by CGIS-S & CGIS-I respectively. Primary criteria - a score of
2 or less i.e. scoring ‘improved and much improved’ rating
were considered ‘good outcome’ on CGIS
• Secondary outcome criteria: clinical improvement as defined
by
• Being not hospitalized for minimum 2 preceding years,
• GAF >80,
• QOL >80,
• >3 on scales of social functions, independent living,
education, and social burden.
• The statistical analysis was performed using SAS, version 9.1.
Probability values less than 0.05 were considered to be
statistically significant.

RESULTS
• Mean duration of untreated psychosis was observed as 12.7 months
(SD =7.3). The majority of patients (73%) had duration of
untreated psychosis ranging between 6 months to 24 months (Table
1).
• There were no differences between short and long DUP in terms of
age at intake and gender (Table 2, p=. 148 and p=. 799,
respectively).
• No statistically significant differences were observed between the
two groups on parameters of clinical and social recovery

Discussion
• There is a well-established association between DUP, critical period and
early intervention. This association is independent of confounding factors,
including premorbid functioning, gender, diagnosis and age of onset of
symptoms variance in functional recovery has been reported 19.
• The finding of 48 weeks DUP in the present study is not surprising from a
developing country where stigma is rampant, awareness is poor,
accessibility of care is limited and resources for mental health are less than
sufficient. A DUP as much as 796 weeks has been reported from India
which is primarily because of lack of availability and accessibility of mental
health services rather than the psychosis remaining ‘unidentified’ 20,21.
• Mental illness remains untreated despite recognition. There are several
cultural, social, religious, economic and personal factors which determine
approach to mental health care which obliviously leads to longer DUP. 22.
Long DUP has also been reported in western literature e.g. a Canadian
study observed duration of untreated psychosis as 84 weeks 23.

• In the present study in a multivariate analysis, results did not
show any statistically significant correlation between various
categories of duration of untreated psychosis and outcome
parameters.
• The significant findings were the lack of correlation with
symptom remission and level of social functions measured by
several psychosocial parameters.
• We compared patients with less than 12 months of DUP and
more than 12 months of DUP and found that no clinical or
social parameters at ten years outcome correlated DUP below
12 months or more than 12 months.
• This lack of association may arise from the followings
possibilities:

Complexity in assessment of DUP.
• Nature of treatment being inadequate because of limited resources
• The long-term outcome in schizophrenia is not influenced by DUP
because most of neuronal changes takes place early in the course or
even preceding the onset and therefore an intervention as late as 12
months does not contribute to long term outcome24
• DUP remains relevant only for short period of follow up and once
the psychosis has persisted long enough, enough toxic damage has
been caused to change any thing in the outcome.
• The finding also indicates that longer the DUP worse the outcome
but a shorter DUP does not necessarily mean a good outcome.
• Further, in our study out of 13 outcome parameters of clinical and
social relevance none of the parameter showed any correlation. All
the parameters most importantly, social function, global function,
quality of life and independent living show no correlation.
•

• It is likely that DUP correlates with outcome measures in
conjunction with several other factors. It further suggests that the
benefit of early intervention in long term is gradually lost, no matter
when the intervention is done due to several factors such as, poor
treatment, lack of follow up, inconsistencies in management, poor
adherence, poor psychosocial intervention & frequent relapses. The
assumption that delay in treating people with psychosis could
impair psychosis while reducing delay would improve it, is not as
straight forward as often stated. 25 There has been continuing
disagreement over whether there is a real association between DUP
and outcome. 3, 26

• We need more studies comparing ultra short DUP, short DUP and
long DUP to understand more clearly about its association with
outcome. Further studies also need to examine how powerful
predictor DUP is? 27.
• Success of this concept depends upon public campaign and
resources for treatments. Research of DUP has given a new
responsibility for community awareness programs for early
identification, which remains a daunting, task everywhere 28, 29 .

SUMMARY AND CONCLUSIONS
• Our study finds that DUP alone does not determine long term
outcome status in first episode schizophrenia. Long DUP leads to
poor outcome and the short DUP does not necessarily lead to good
outcome due to psychopathological heterogeneity in early phase.
30,31,32 ... There is a missing link in association of DUP and outcome.
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